Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Cudafol and Diprivan in Healthy Subjects
NCT02713802Phase 1Completed
- Sponsor
- Cuda Pharmaceuticals
- Start
- Mar 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Cudafol in general anesthesia (2 arms), sponsored by Cuda Pharmaceuticals. Primary endpoints: Area Under Curve and Maximum Plasma Concentration. Started Mar 2016; status: completed.
02
Drugs
Cudafol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT02713802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713802.